289 related articles for article (PubMed ID: 26017006)
1. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
Malar J; 2015 May; 14():218. PubMed ID: 26017006
[TBL] [Abstract][Full Text] [Related]
2. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Clemmer L; Martins YC; Zanini GM; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2011 Apr; 55(4):1383-90. PubMed ID: 21220531
[TBL] [Abstract][Full Text] [Related]
3. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
[TBL] [Abstract][Full Text] [Related]
5. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
6. RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells.
Oronsky B; Scicinski J; Reid T; Oronsky A; Carter C; Oronsky N; Cabrales P
Discov Med; 2016 Apr; 21(116):251-65. PubMed ID: 27232511
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P
Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661
[TBL] [Abstract][Full Text] [Related]
8. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.
Cabrales P; Zanini GM; Meays D; Frangos JA; Carvalho LJ
Am J Pathol; 2010 Mar; 176(3):1306-15. PubMed ID: 20110412
[TBL] [Abstract][Full Text] [Related]
9. G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of
Yi H; Jiang W; Yang F; Li F; Li Y; Zhu W; Li Q; Fakhar SH; Cao Y; Luo L; Zhang W; He Y
Front Immunol; 2021; 12():719189. PubMed ID: 34456927
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether.
Prada J; Müller S; Bienzle U; Kremsner PG
J Antimicrob Chemother; 1996 Jul; 38(1):95-102. PubMed ID: 8858461
[TBL] [Abstract][Full Text] [Related]
11. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
Orjuela-Sánchez P; Ong PK; Zanini GM; Melchior B; Martins YC; Meays D; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
[TBL] [Abstract][Full Text] [Related]
13. Glucose 6-phosphate dehydrogenase 6-phosphogluconolactonase: characterization of the Plasmodium vivax enzyme and inhibitor studies.
Haeussler K; Berneburg I; Jortzik E; Hahn J; Rahbari M; Schulz N; Preuss J; Zapol'skii VA; Bode L; Pinkerton AB; Kaufmann DE; Rahlfs S; Becker K
Malar J; 2019 Jan; 18(1):22. PubMed ID: 30683097
[TBL] [Abstract][Full Text] [Related]
14. RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature.
Jani VP; Asaro R; Oronsky B; Cabrales P
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946824
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.
Dormoi J; Briolant S; Desgrouas C; Pradines B
Antimicrob Agents Chemother; 2013 Jul; 57(7):3412-4. PubMed ID: 23612202
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.
Wilson NO; Solomon W; Anderson L; Patrickson J; Pitts S; Bond V; Liu M; Stiles JK
PLoS One; 2013; 8(4):e60898. PubMed ID: 23630573
[TBL] [Abstract][Full Text] [Related]
17. A unique insertion in Plasmodium berghei glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: evolutionary and functional studies.
Clarke JL; Sodeinde O; Mason PJ
Mol Biochem Parasitol; 2003 Mar; 127(1):1-8. PubMed ID: 12615331
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target.
Allen SM; Lim EE; Jortzik E; Preuss J; Chua HH; MacRae JI; Rahlfs S; Haeussler K; Downton MT; McConville MJ; Becker K; Ralph SA
FEBS J; 2015 Oct; 282(19):3808-23. PubMed ID: 26198663
[TBL] [Abstract][Full Text] [Related]
19. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
Gumede B; Folb P; Ryffel B
Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Guo J; Guiguemde AW; Bentura-Marciano A; Clark J; Haynes RK; Chan WC; Wong HN; Hunt NH; Guy RK; Golenser J
Antimicrob Agents Chemother; 2012 Jan; 56(1):163-73. PubMed ID: 22006004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
